Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 301–360 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…inhibitors (4), tumour necrosis factor (TNF) inhibitors (1) and tocilizumab (1). Pooled analysis showed no significant overall change in FV…
…n in pain score was greater in the PENG block group than in the intravenous morphine group (−6 (IQR−6 to −5) vs −3 (IQR −5 to −2); p=0.001). General…
…al of Pharmacy Research 2008;1(2):188–191.2. Wilson SE. Topical losartan: practical guidance for clinical trials in the prevention and t…
…h) and 292.5 ± 3.54 mOsm/L (48 h), both within the target range.Amikacin recovery percentages were 99.78 ± 0.99% (2 h), 100 ± 0.35% (4 h…
…Background and Importance Cladribine is an immunosuppressive drug used in relapsing–remitting multip…
…n = 15; 95% CI: 49.7%–86.3%) achieved fluid reduction following verteporfin PDT. ARs occurred in three patients (6%), with secondary choroi…
…r centre’s experience.Aim and Objectives To evaluate the use of faricimab and its economic impact from the hospital pharmacy perspective.…
… constipation, nausea, and weight loss.Conclusion and Relevance Gepants used in the treatment of migraine appear to reduce migraine day…
…ary 2025) was conducted including all PsA patients treated with secukinumab monotherapy.Data were collected from electronic records and the…
…arratively.Results Eight studies met inclusion criteria. SSRIs (fluoxetine, sertraline, escitalopram, citalopram) consistently improved de…
…ded to confirm these findings about safety and effectiveness of talquetamab.Conflict of Interest No conflict of interest…
…adherence, and safety of long-acting intramuscular cabotegravir/rilpivirine (CAB/RPV) in PLHIV.Material and Methods This was a retrospectiv…